id: NEW:buprenorphine_prescriber_waiver_status_to_sud_medication_treatment_rate_oud
name: Buprenorphine Prescriber Waiver Status â†’ SUD Medication Treatment Rate (OUD)
from_node:
  node_id: NEW:buprenorphine_prescriber_waiver_status
  node_name: Buprenorphine Prescriber Waiver Status
to_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: SUD Medication Treatment Rate (OUD)
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Federal waiver requirements create regulatory barriers for NPs/PAs to prescribe buprenorphine'
- 'Step 2: Waivered providers have different perceived barriers than non-waivered providers'
- 'Step 3: Waivered providers report insurance prior authorization and detoxification access as key barriers'
- 'Step 4: These structural healthcare system barriers limit buprenorphine prescribing even among waivered
  providers'
- 'Step 5: Reduced prescribing capacity leads to lower medication treatment rates for OUD patients'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: B. Andraka-Christou et al. 2022. "Perceptions of buprenorphine barriers and efficacy
    among nurse practitioners and physician assistants." https://doi.org/10.1186/s13722-022-00321-6
  supporting_citations:
  - Additional citations require full-text access
  doi: 10.1186/s13722-022-00321-6
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Federal waiver requirements and associated structural barriers (insurance prior authorization,
  detoxification access) limit NP/PA buprenorphine prescribing capacity, contributing to underutilization
  of evidence-based medication treatment for OUD
quantitative_effects:
  sample_size: 240
spatial_variation:
  varies_by_geography: true
  variation_notes: Buprenorphine is underutilized nationally, particularly in rural areas where NPs/PAs
    could help address treatment gaps
moderators:
- name: waiver_status
  direction: strengthens
  strength: moderate
  description: Waivered versus non-waivered NPs/PAs perceive different barriers to prescribing, with non-waivered
    providers more concerned about patient mix
- name: rural_location
  direction: strengthens
  strength: moderate
  description: Rural areas have greater underutilization of buprenorphine, making NP/PA prescribing more
    critical
structural_competency:
  equity_implications: This mechanism highlights structural healthcare policy barriers rather than individual
    provider deficits. The waiver system creates regulatory obstacles that differentially affect mid-level
    providers. Insurance prior authorization requirements and lack of detox beds are systemic healthcare
    infrastructure problems, not individual failures.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.242012'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
